1955
DOI: 10.1042/bj0610534
|View full text |Cite
|
Sign up to set email alerts
|

The N-terminal and sulphur-containing residues of bacitracin A

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0

Year Published

1956
1956
1995
1995

Publication Types

Select...
4
2
2

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(9 citation statements)
references
References 27 publications
0
9
0
Order By: Relevance
“…Desulphurized bacitracin. This was prepared by treating commercial bacitracin with Raney nickel as described by Lockhart et al (1955).…”
Section: Bacitracin U8ed For Hydrolysismentioning
confidence: 99%
See 1 more Smart Citation
“…Desulphurized bacitracin. This was prepared by treating commercial bacitracin with Raney nickel as described by Lockhart et al (1955).…”
Section: Bacitracin U8ed For Hydrolysismentioning
confidence: 99%
“…Experiments on the Lysine and Aspartic Acid Residues in Bacitracin A BY I. M. LOCKHART AND E. P. ABRAHAM Sir William Dunn School of Pathology, University of Oxford (Received 19 September 1955) In several structural features the bacitracin family appears to be unique among polypeptides that have so far been subjected to detailed chemical study. The N-terminal and sulphur-containing residues in bacitracin A have been discussed in an earlier paper (Lockhart, Abraham & Newton, 1955). In addition to this portion of the molecule, the lysine residue is a centre of interest.…”
mentioning
confidence: 99%
“…The components of 6,7,10,ll,12,13,15 and 16,andpeaksNo. 24,25,26,27,28,29 and 31 Comparison of the MICsand the proposed structures of the minor componentssuggest that the location of the valine affects the activity of each component in the following decreasing order: TV-terminus, the seven membered peptide ring, and the side chain peptide moiety. Because this order is related to the elution order of the minor components on the HPLC, the activity may depend on the hydrophobicity of the respective component.…”
Section: Confirmation Of Proposed Structures By Lc/ms and Ms/msmentioning
confidence: 99%
“…7,10,ll,12,13,15,16,24,25,26,27,28,29and 31 as indicated in Fig. 1 Table 1 were considered to be all D-alloisoleucines derived from TV-terminal L -isoleucines.…”
Section: Determination Of Minimal Inhibition Concentrationmentioning
confidence: 99%
“…Moreover, in long-term experiments D-valine inhibited total antibiotic synthesis by this organism without inhibiting cell growth 51 and also inhibited the incorporation of 1-14 C-L-valine into the antibiotic. However, the penicillins may represent a special case, since it is a plausible hypothesis that their thiazolidine ring is formed by the addition of the thiol group of a cysteine residue to the double bond of a residue of 2,3-dehydrovaline, and this could result in the formation of a D centre, irrespective of the configuration of the original valine precursor (VIII) 54 residues play a wider role in the formation of D centres in peptide antibiotics is not known, but a residue of dehydrotryptophan has been found to occur in telomycin 16 , and racemisation in the N-terminal isoleucine residue of bacitracin appears to be facilitated by resonance 56 (see next page). 1-14 C-L-Valine was found to be incorporated much more efficiently into benzylpenicillin than D-valine, even though the uptake of the D-isomer was not very much less than that of the L-isomer 53 .…”
Section: T H E O R I G I N Of D -A M I N O a C I D Residuesmentioning
confidence: 99%